Jeffrey Stein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey Stein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Stein. Jeffrey Stein is Director in Paratek Pharmaceuticals, Inc. ($PRTK) and President and CEO in Trius Therapeutics Inc ($TSRX) and President & CEO in Cidara Therapeutics, Inc. ($CDTX) and Director in IDEAYA Biosciences, Inc. ($IDYA).
Latest Insider Trading Transactions of Jeffrey Stein
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CDTX, IDYA, PRTK, TSRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 361,878 | 351.9 K to 361.9 K (+2.84 %) |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 9,000 | 0 | 35,625 | 26.6 K to 35.6 K (+33.80 %) |
| Nov 12 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 2.00 | 50,000 | 100,015 | 347,878 | 297.9 K to 347.9 K (+16.79 %) |
| Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Stein Jeffrey | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 1.98 | 330,000 | 653,400 | 330,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 3.51 | 7,000 | 24,570 | 7,000 | |
| Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 9,000 | 0 | 26,625 | 17.6 K to 26.6 K (+51.06 %) |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | X | 2.51 | 32,283 | 81,030 | 0 | |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | X | 2.51 | 7,558 | 18,971 | 0 | |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | X | 2.51 | 32,283 | 81,030 | 257,902 | 225.6 K to 257.9 K (+14.31 %) |
| Jan 30 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | X | 2.51 | 7,558 | 18,971 | 293,878 | 286.3 K to 293.9 K (+2.64 %) |
| Dec 19 2019 | IDYA | IDEAYA Biosciences ... | Stein Jeffrey | Director | Option Exercise | A | 9.15 | 1,250 | 11,438 | 1,250 | |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 1.91 | 52,500 | 100,102 | 225,619 | 173.1 K to 225.6 K (+30.33 %) |
| Sep 26 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 1.91 | 52,500 | 100,102 | 225,619 | 173.1 K to 225.6 K (+30.33 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | M | 0.00 | 10,000 | 0 | 50,000 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 282,320 | 272.3 K to 282.3 K (+3.67 %) |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.61 | 265,000 | 691,650 | 265,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.61 | 265,000 | 691,650 | 265,000 | |
| Mar 13 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 10,670 | 0 | 15,709 | 5 K to 15.7 K (+211.75 %) |
| Mar 13 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 21,340 | 0 | 173,119 | 194.5 K to 173.1 K (-10.97 %) |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 7.23 | 5,000 | 36,150 | 5,000 | |
| Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 7,500 | 0 | 17,625 | 10.1 K to 17.6 K (+74.07 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Sell | S | 7.14 | 3,375 | 24,098 | 10,125 | 13.5 K to 10.1 K (-25.00 %) |
| Feb 20 2019 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Sell | S | 7.14 | 3,375 | 24,098 | 10,125 | 13.5 K to 10.1 K (-25.00 %) |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | M | 0.00 | 60,000 | 0 | 60,000 | |
| Dec 04 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 4,619 | 0 | 5,039 | 420 to 5 K (+1,099.76 %) |
| Dec 04 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Gift | G | 0.00 | 9,238 | 0 | 194,459 | 203.7 K to 194.5 K (-4.54 %) |
| May 24 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 6.81 | 250,000 | 1,702,500 | 250,000 | |
| May 24 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 4.70 | 212,766 | 1,000,000 | 268,320 | 55.6 K to 268.3 K (+382.99 %) |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 4.00 | 235,000 | 940,000 | 235,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 14.15 | 5,000 | 70,750 | 5,000 | |
| Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 7,500 | 0 | 13,500 | 6 K to 13.5 K (+125.00 %) |
| Sep 12 2017 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 6.79 | 7,350 | 49,907 | 51,851 | 44.5 K to 51.9 K (+16.52 %) |
| Jun 07 2017 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 5.95 | 15,000 | 89,211 | 44,501 | 29.5 K to 44.5 K (+50.85 %) |
| Apr 04 2017 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 7.80 | 220,000 | 1,716,000 | 220,000 | |
| Apr 04 2017 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 7.75 | 12,900 | 99,975 | 27,196 | 14.3 K to 27.2 K (+90.24 %) |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 15.10 | 6,000 | 90,600 | 6,000 | |
| Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| May 23 2016 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 11.51 | 4,310 | 49,608 | 203,697 | 199.4 K to 203.7 K (+2.16 %) |
| Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 14.05 | 12,000 | 168,600 | 12,000 | |
| Mar 18 2016 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 9.89 | 159,000 | 1,572,510 | 159,000 | |
| Nov 27 2015 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 15.60 | 1,300 | 20,280 | 6,700 | 5.4 K to 6.7 K (+24.07 %) |
| Nov 27 2015 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 14.97 | 5,400 | 80,838 | 5,400 | 0 to 5.4 K |
| Apr 21 2015 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 16.00 | 420 | 6,720 | 420 | 0 to 420 |
| Mar 11 2013 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Option Exercise | A | 6.13 | 275,000 | 1,685,750 | 275,000 | |
| Dec 16 2010 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Option Exercise | M | 0.52 | 22,700 | 11,804 | 119,742 | |
| Dec 16 2010 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Buy | M | 0.52 | 22,700 | 11,804 | 171,995 | 149.3 K to 172 K (+15.20 %) |
| Nov 05 2010 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Option Exercise | A | 3.50 | 30,000 | 105,000 | 30,000 | |
| Nov 05 2010 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Option Exercise | A | 3.50 | 170,000 | 595,000 | 170,000 | |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Option Exercise | C | 0.00 | 45,454 | 0 | 0 | |
| Aug 10 2010 | TSRX | Trius Therapeutics ... | Stein Jeffrey | President and CEO | Buy | C | 0.00 | 5,285 | 0 | 149,295 | 144 K to 149.3 K (+3.67 %) |
Page: 1